Metraipolis › archive › dc_0556ee2db05a

Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41097761
DOI
10.3390/cancers17193235
License (as archived)
solo-consultazione
Archived
2026-11-09T13:55:25.491Z
SHA-256 of the archived text
e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c
Stable URL of this page
https://metraipolis.com/documento/dc_0556ee2db05a

How to cite

Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761 — Europe PMC (en), https://europepmc.org/article/MED/41097761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0556ee2db05a (Metraipolis archive dc_0556ee2db05a, sha256 e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c)
BibTeX
@misc{dc0556ee2db05a,
  title = {Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097761},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0556ee2db05a; sha256 e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097761. Agents can read the archived copy with the MCP tool read_document.